본문 바로가기
KERD
논문KCI 등재

Clinical practice guideline and real-life practice in hepatocellular carcinoma: A Korean perspective

Min Woo Lee|Jeong Il Yu|Jong Man Kim|Dong Hyun Sinn|Myung Ji Goh|Dong Ho Hyun|Jung Yong Hong|Moon Seok Choi
대한간학회 (The korean Association for the Study of the Liver)|2023.04|Clinical and Molecular Hepatology|제29권 제2호|pp. 197-205

2

조회

0

다운로드

8

인용

0

참고문헌

키워드

TreatmentDiagnosisClinical practice guidelineSurveillanceHepatocellular carcinoma

초록

Hepatocellular carcinoma (HCC) is a major cause of death in many countries, including South Korea. To provide useful and sensible advice for clinical management of patients with HCC, the Korean Liver Cancer Association and National Cancer Center Korea Practice Guideline Revision Committee have recently revised the practice guidelines for HCC management. However, there are some differences between practice guidelines and real-life clinical practice. In this review, we describe some key recommendations of the 2022 version of practice guidelines and the real-life clinical situation in South Korea, together with discussion about efforts needed to reduce the difference between guidelines and real-life clinical practice.

Abstract

Hepatocellular carcinoma (HCC) is a major cause of death in many countries, including South Korea. To provide useful and sensible advice for clinical management of patients with HCC, the Korean Liver Cancer Association and National Cancer Center Korea Practice Guideline Revision Committee have recently revised the practice guidelines for HCC management. However, there are some differences between practice guidelines and real-life clinical practice. In this review, we describe some key recommendations of the 2022 version of practice guidelines and the real-life clinical situation in South Korea, together with discussion about efforts needed to reduce the difference between guidelines and real-life clinical practice.

참고문헌 (33)

  1. Korean Liver Cancer Association (KLCA), "2022 KLCA-NCC Korea practice guidelines for the management of hepatocellular carcinoma", Clinical and Molecular Hepatology, 28(4), pp.583~705 (2022), 대한간학회
  2. Young Eun Chon, "Hepatocellular carcinoma statistics in South Korea", Clinical and Molecular Hepatology, 27(3), pp.512~514 (2021), 대한간학회[DOI]
  3. Park JW, "Practice guideline for diagnosis and treatment of hepatocellular carcinoma", Korean J Hepatol, 10, pp.88~98 (2004)
  4. Korean Liver Cancer Study Group and National Cancer Center, Korea, "Practice guidelines for management of hepatocellular carcinoma 2009", Korean J Hepatol, 15, pp.391~423 (2009)
  5. 한국 간 암 스터디그룹, "2014 KLCSG-NCC Korea Practice Guideline for the Management of Hepatocellular Carcinoma", Gut and Liver, 9(3), pp.267~317 (2015), 거트앤리버 소화기연관학회협의회
  6. Korean Liver Cancer Association (KLCA) and National Cancer Center (NCC, "2018 Korean Liver Cancer Association–National Cancer Center Korea Practice Guidelines for the Management of Hepatocellular Carcinoma", Gut and Liver, 13(3), pp.227~299 (2019), 거트앤리버 소화기연관학회협의회[DOI]
  7. Schünemann HJ, "Grading quality of evidence and strength of recommendations for diagnostic tests and strategies", BMJ, 336, pp.1106~1110 (2008)
  8. 전영은, "Hepatocellular Carcinoma in Korea between 2012 and 2014: an Analysis of Data from the Korean Nationwide Cancer Registry", Journal of Liver Cancer, 20(2), pp.135~147 (2020), 대한간암학회[DOI]
  9. Sinn DH, "Late presentation of hepatitis B among patients with newly diagnosed hepatocellular carcinoma : a national cohort study", BMC Cancer, 19, pp.286~ (2019)
  10. Kim Y, "Overview of the National Cancer screening programme and the cancer screening status in Korea", Asian Pac J Cancer Prev, 12, pp.725~730 (2011)
  11. Won Sohn, "A Survey of Liver Cancer Specialists’ Views on the National Liver Cancer Screening Program in Korea", Journal of Liver Cancer, 20(1), pp.53~59 (2020), 대한간암학회[DOI]
  12. Won Sohn, "Impact of nationwide hepatocellular carcinoma surveillance on the prognosis in patients with chronic liver disease", Clinical and Molecular Hepatology, 28(4), pp.851~863 (2022), 대한간학회
  13. Kim DH, "Surveillance failure in ultrasound for hepatocellular carcinoma : a systematic review and meta-analysis", Gut, 71, pp.212~213 (2022)
  14. 김연윤, "Failure of hepatocellular carcinoma surveillance: inadequate echogenic window and macronodular parenchyma as potential culprits", ULTRASONOGRAPHY, 38(4), pp.311~320 (2019), 대한초음파의학회[DOI]
  15. Sinn DH, "Incidence and risk factors for surveillance failure in patients with regular hepatocellular carcinoma surveillance", Hepatol Int, 7, pp.1010~1018 (2013)
  16. Yoon JH, "A comparison of biannual two-phase low-dose liver CT and US for HCC surveillance in a group at high risk of HCC development", Liver Cancer, 9, pp.503~517 (2020)
  17. Kim SY, "MRI with liverspecific contrast for surveillance of patients with cirrhosis at high risk of hepatocellular carcinoma", JAMA Oncol, 3, pp.456~463 (2017)
  18. Tae-Hyung Kim, "Comparison of international guidelines for noninvasive diagnosis of hepatocellular carcinoma: 2018 update", Clinical and Molecular Hepatology, 25(3), pp.245~263 (2019), 대한간학회
  19. Junghoan Park, "Imaging diagnosis of hepatocellular carcinoma: Future directions with special emphasis on hepatobiliary magnetic resonance imaging and contrast-enhanced ultrasound", Clinical and Molecular Hepatology, 28(3), pp.362~379 (2022), 대한간학회[DOI]
  20. 이상민, "Diagnostic Performance of 2018 KLCA-NCC Practice Guideline for Hepatocellular Carcinoma on Gadoxetic Acid-Enhanced MRI in Patients with Chronic Hepatitis B or Cirrhosis: Comparison with LI-RADS Version 2018", Korean Journal of Radiology, 22(7), pp.1066~1076 (2021), 대한영상의학회[DOI]
  21. 이선영, "Comparison of LI-RADS 2018 and KLCA-NCC 2018 for noninvasive diagnosis of hepatocellular carcinoma using magnetic resonance imaging", Clinical and Molecular Hepatology, 26(3), pp.340~351 (2020), 대한간학회[DOI]
  22. Jeon SK, "Comparison of guidelines for diagnosis of hepatocellular carcinoma using gadoxetic acid-enhanced MRI in transplantation candidates", Eur Radiol, 30, pp.4762~4771 (2020)
  23. 김남중, "Noninvasive Diagnostic Criteria of the Revised 2014 the Korean Liver Cancer Study Group and the National Cancer Center Guideline for Subcentimetersized Hepatocellular Carcinoma: Is It Too Strict?", Journal of Liver Cancer, 18(1), pp.44~50 (2018), 대한간암학회[DOI]
  24. Song KD, "Subcentimeter hypervascular nodule with typical imaging findings of hepatocellular carcinoma in patients with history of hepatocellular carcinoma : natural course on serial gadoxetic acid-enhanced MRI and diffusion-weighted imaging", Eur Radiol, 25, pp.2789~2796 (2015)
  25. Sinn DH, "Multidisciplinary approach is associated with improved survival of hepatocellular carcinoma patients", PLoS One, 14, pp.e0210730~ (2019)
  26. Sinn DH, "Patterns and outcomes in hepatocellular carcinoma patients with portal vein invasion : a multicenter prospective cohort study", Dig Dis Sci, 66, pp.315~324 (2021)
  27. Kim KM, "The recommended treatment algorithms of the BCLC and HKLC staging systems : does following these always improve survival rates for HCC patients?", Liver Int, 36, pp.1490~1497 (2016)
  28. Kim BK, "Changes in real-life practice for hepatocellular carcinoma patients in the Republic of Korea over a 12-year period : A nationwide random sample study", PLoS One, 14, pp.e0223678~ (2019)
  29. Jae Seung Lee, "A survey on transarterial chemoembolization refractoriness and a real-world treatment pattern for hepatocellular carcinoma in Korea", Clinical and Molecular Hepatology, 26(1), pp.24~32 (2020), 대한간학회
  30. Kang H, "Mapping Korean National Health Insurance reimbursement claim codes for therapeutic and surgical procedures to SNOMED-CT to facilitate data reuse", Stud Health Technol Inform, 290, pp.101~105 (2022)
  31. Cho DY, "The impact of expanding health insurance coverage for anti-cancer drugs on cancer survival in Korea", Cancer Med, 10, pp.4555~4563 (2021)
  32. Rayzah Musaed, "Changes in Korean National Healthcare Insurance Policy and Breast Cancer Surgery Trend in Korea", Journal of Korean Medical Science, 36(29), pp.1~9 (2021), 대한의학회[DOI]
  33. Lee HW, "Advancements of liver transplantation for hepatocellular carcinoma in Korea", Jpn J Clin Oncol, 47, pp.93~100 (2017)

관련 논문AI추천

2022 KLCA-NCC Korea practice guidelines for the management of hepatocellular carcinomaKorean Liver Cancer Association (KLCA), National Cancer Center (NCC) Korea대한간학회 · Clinical and Molecular Hepatology2022 · 제28권 제4호2018 Korean Liver Cancer Association–National Cancer Center Korea Practice Guidelines for the Management of Hepatocellular CarcinomaKorean Liver Cancer Association (KLCA) and National Cancer Center (NCC거트앤리버 소화기연관학회협의회 · Gut and Liver2019 · 제13권 제3호Clinical practice guidelines and real-life practice in hepatocellular carcinoma: A Japanese perspectiveHideki Iwamoto, Hironori Koga, Hiroyuki Suzuki, Masahito Nakano, Shigeo Shimose, Takumi Kawaguchi대한간학회 · Clinical and Molecular Hepatology2023 · 제29권 제2호What should be done to reduce the discrepancy between guidelines and real-life practice for hepatocellular carcinoma in Korea?Min Kyung Park, Yoon Jun Kim대한간학회 · Clinical and Molecular Hepatology2023 · 제29권 제2호2014 KLCSG-NCC Korea Practice Guideline for the Management of Hepatocellular Carcinoma한국 간 암 스터디그룹, 국립 암 센터거트앤리버 소화기연관학회협의회 · Gut and Liver2015 · 제9권 제3호Overview of Asian clinical practice guidelines for the management of hepatocellular carcinoma: An Asian perspective comparisonBo Hyun Kim, Joong-Won Park, Yuri Cho대한간학회 · Clinical and Molecular Hepatology2023 · 제29권 제2호

이 간행물의 다른 논문 (53건)

Congratulatory remarksSi Hyun Baepp. 1-1Special thanksSeung Up Kimpp. 4-4MAFLD: How is it different from NAFLD?Ming-Hua Zheng, Jacob George, Cameron Gofton, Yadhavan Upendranpp. 17-31Global incidence and prevalence of nonalcoholic fatty liver diseaseEunice Tan, Mark D. Muthiah, Cheng Han Ng, Margaret LP Teng, Kai En Chan, Darren JH Tan, Wen Hui Lim, Ju Dong Yang, Daniel Q. Huangpp. 32-42Nonalcoholic fatty liver disease and non-liver comorbiditiesRichie Manikat, Mindie H. Nguyenpp. 86-102
원문 보기